Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma.

Hideki GotoDaisuke HidakaSatoshi YamamotoKoji HayasakaRie MichimataIkuko KagawaKana SunagoyaHiroaki IijimaEiko HayaseSouichi ShiratoriKohei OkadaJunichi SugitaMasahiro OnozawaDaigo HashimotoKaoru KahataKatsuya FujimotoTomoyuki EndoChikara ShimizuTakanori Teshimanull null

Published in: Journal of clinical apheresis (2020)

Our data indicated that a single dose of 3.6 mg pegfilgrastim on day 7 after chemotherapy safely and effectively mobilized CD34+ cells.

Keyphrases

low dose
induced apoptosis
chemotherapy induced
single cell
cell cycle arrest
high dose
diffuse large b cell lymphoma
peripheral blood
electronic health record
big data
endoplasmic reticulum stress
locally advanced
stem cells
signaling pathway